Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses-Reference-Cited by-同舟云学术

Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses

Published:2010-12-20 Issue:5 Volume:152 Page:551-560
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Gallamini Andrea,Patti Caterina,Viviani Simonetta,Rossi Andrea,Fiore Francesca,Di Raimondo Francesco,Cantonetti Maria,Stelitano Caterina,Feldman Tatyana,Gavarotti Paolo,Sorasio Roberto,Mulè Antonino,Leone Monica,Rambaldi Alessandro,Biggi Alberto,Barrington Sally,Fallanca Federico,Ficola Umberto,Chauvie Stéphane,Gianni Alessandro Massimo,

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2010.08485.x/fullpdf

Reference48 articles.

1. Two cycles of escalated BEACOPP followed by four cycles of ABVD utilizing early-interim PET/CT scan is an effective regimen for advanced high-risk Hodgkin’s lymphoma;Avigdor;Annals of Oncology,2010

2. Concordance between four European Centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma;Barrington;European Journal of Nuclear Medicine and Molecular Imaging,2010

3. Secondary amenorrhea after Hodgkin’s lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin’s Lymphoma Study Group;Behringer;Journal of clinical Oncology,2005

4. FDG-PET: procedure guidelines for tumor imaging;Bombardieri;European Journal of Nuclear Medicine and Molecular Imaging,2003

5. Survival in Hodgkin’s disease patients - Report of 25 years of experience at the Milan cancer Institute;Bonadonna;European Journal of Cancer,2005

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduced Corticosteroid Exposure Is Safe and Does Not Reduce Disease Control among Hodgkin Lymphoma Patients Treated with Escalated BEACOPP (eBEACOPP);Medicina;2024-03-02

2. Visual and quantitative assessment of interim <sup>18</sup>F-fluorodeoxyglucose-positron emission tomography/computed tomography in children with Hodgkin lymphoma;Pediatric Hematology/Oncology and Immunopathology;2023-11-09

3. Incorporating Monoclonal Antibodies into the First-Line Treatment of Classical Hodgkin Lymphoma;International Journal of Molecular Sciences;2023-08-24

4. Minimising the Toxicities of First Line Hodgkin Lymphoma Treatment in the Modern Era;Cancers;2022-11-01

5. Whole-body MRI radiomics model to predict relapsed/refractory Hodgkin Lymphoma: A preliminary study;Magnetic Resonance Imaging;2022-02